Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.

Stattin, Pär ; Vickers, Andrew J ; Sjoberg, Daniel D ; Johansson, Robert ; Granfors, Torvald ; Johansson, Mattias ; Pettersson, Kim ; Scardino, Peter T ; Hallmans, Göran and Lilja, Hans LU orcid (2015) In European Urology 68(2). p.207-213
Abstract
A disadvantage of prostate-specific antigen (PSA) for the early detection of prostate cancer (PCa) is that many men must be screened, biopsied, and diagnosed to prevent one death.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Urology
volume
68
issue
2
pages
207 - 213
publisher
Elsevier
external identifiers
  • pmid:25682340
  • wos:000360571400017
  • scopus:84937514041
  • pmid:25682340
ISSN
1873-7560
DOI
10.1016/j.eururo.2015.01.009
language
English
LU publication?
yes
id
c76825be-b4c2-4270-8397-180bf1f95a19 (old id 5143636)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25682340?dopt=Abstract
date added to LUP
2016-04-01 11:04:07
date last changed
2022-05-06 03:57:44
@article{c76825be-b4c2-4270-8397-180bf1f95a19,
  abstract     = {{A disadvantage of prostate-specific antigen (PSA) for the early detection of prostate cancer (PCa) is that many men must be screened, biopsied, and diagnosed to prevent one death.}},
  author       = {{Stattin, Pär and Vickers, Andrew J and Sjoberg, Daniel D and Johansson, Robert and Granfors, Torvald and Johansson, Mattias and Pettersson, Kim and Scardino, Peter T and Hallmans, Göran and Lilja, Hans}},
  issn         = {{1873-7560}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{207--213}},
  publisher    = {{Elsevier}},
  series       = {{European Urology}},
  title        = {{Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.}},
  url          = {{https://lup.lub.lu.se/search/files/2353857/8056874}},
  doi          = {{10.1016/j.eururo.2015.01.009}},
  volume       = {{68}},
  year         = {{2015}},
}